Toradol and Rocephin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Toradol (ketorolac tromethamine) and Rocephin (ceftriaxone sodium). Common drug interactions include injury among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Toradol and Rocephin. It is created by eHealthMe based on reports of 253 people who take the same drugs from the FDA, and is updated regularly.
What is Toradol?
Toradol has active ingredients of ketorolac tromethamine. It is often used in pain. eHealthMe is studying from 9,231 Toradol users. Check the latest studies of Toradol.
What is Rocephin?
Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
253 people who take Toradol and Rocephin together, and have interactions are studied.
What are the common drug interactions of Toradol and Rocephin, by gender? *
What are the common drug interactions of Toradol and Rocephin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Toradol and Rocephin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Toradol and Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Toradol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Toradol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocephin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ketorolac tromethamine and ceftriaxone sodium (the active ingredients of Toradol and Rocephin, respectively), and Toradol and Rocephin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Hydroxyzine Hydrochloride and Nifedipine - 3 seconds ago
- Could Humira cause Thyroid Operation? - 4 seconds ago
- Drug interactions of Minipress and Revlimid - 6 seconds ago
- Could Bacillus Coagulans cause Asthma Aggravated? - 7 seconds ago
- Could Entyvio cause Colitis Microscopic? - 8 seconds ago
- Could Clopra cause Muscle Haemorrhage? - 10 seconds ago
- Acne and High Blood Pressure - 11 seconds ago
- Could Takhzyro cause Drowsiness? - 16 seconds ago
- Drug interactions of Zoledronic and Ibandronate Sodium - 17 seconds ago
- Could Tacrolimus cause Ventricular Tachycardia? - 45 seconds ago